COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES USING REAL WORLD DATA FROM BRAZILIAN HEALTH CARE INSURANCE COMPANIES IN THE TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE

被引:0
|
作者
Campagnaro, M. [1 ]
Malard, W. [2 ]
Clemente, V [3 ]
Nunes, A. A. [4 ]
机构
[1] CSL Vifor, Sao Paulo, SP, Brazil
[2] CSL Vifor, Ribeirao Preto, SP, Brazil
[3] CSL Vifor, Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Ribeirao Preto, SP, Brazil
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE467
引用
收藏
页码:S141 / S141
页数:1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT OF CONCOR® AM VERSUS BISOPROLOL PLUS AMLODIPINE IN SYSTEMIC ARTERIAL HYPERTENSION TREATMENT, FROM THE PERSPECTIVE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Fujii, R. K.
    Restrepo, M.
    Fernandes, R. A.
    Haas, L.
    Pepe, C.
    Junqueira, M.
    VALUE IN HEALTH, 2015, 18 (03) : A138 - A138
  • [42] Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn's disease using real world evidence in Thailand
    Phisalprapa, Pochamana
    Kositamongkol, Chayanis
    Limsrivilai, Julajak
    Aniwan, Satimai
    Charatcharoenwitthaya, Phunchai
    Pisespongsa, Pises
    Kitiyakara, Taya
    Treepongkaruna, Suporn
    Chaiyakunapruk, Nathorn
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (11) : 1302 - 1310
  • [43] THE COST-EFFECTIVENESS OF OPIOID AGONIST TREATMENT AMONG OPIOID DEPENDENT INDIVIDUALS: EVIDENCE FROM THE REAL-WORLD DATA
    Chang, Kun Chia
    Lee, Kuan Ying
    Lu, Tsung Hsueh
    Der Wang, Jung
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : I12 - I13
  • [44] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF INTRA-ARTICULAR SODIUM HYALURONATE VERSUS TOTAL ARTHROPLASTY IN THE TREATMENT OF KNEE OSTEOARTHRITIS UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE
    Fernandes, R. A.
    Quintella, F. F.
    Teich, V
    Carvalho, J. C. N.
    Molinari, M. B.
    Krambek, M. C.
    VALUE IN HEALTH, 2009, 12 (07) : A437 - A437
  • [45] A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model
    Blommestein, Hedwig M.
    Verelst, Silvia G. R.
    de Groot, Saskia
    Huijgens, Peter C.
    Sonneveld, Pieter
    Uyl-de Groot, Carin A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (02) : 198 - 208
  • [46] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF SELECTIVE INTERNAL RADIATION THERAPY VEPSUS ATEZOLIZUMAB PLUS BEVACIZUMAIT FROM A GERMAN STATUTORY HEALTH INSURANCE PERSPECTIVE
    Schwander, B.
    Klesper, K.
    Rosso, S.
    Herrmann, K.
    Zoellner, Y. F.
    VALUE IN HEALTH, 2022, 25 (12) : S167 - S167
  • [47] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSES OF RISK STRATIFICATION OF PATIENTS WITH MODERATE RISK OF CARDIOVASCULAR EVENTS USING LP-PLA2 TESTING
    Rinde, H.
    Genser, B.
    Sonntag, D.
    Kleber, M. E.
    Stojakovic, T.
    Scharnagl, H.
    Maerz, W.
    VALUE IN HEALTH, 2014, 17 (07) : A481 - A481
  • [48] BUDGET-IMPACT AND COST-EFFECTIVENESS OF TILDRAKIZUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS FROM A US HEALTH PLAN PERSPECTIVE
    Carrico, J.
    Jia, X.
    Zhao, Y.
    Zhang, J.
    Brodtkorb, T. H.
    Mendelsohn, A. B.
    Lowry, S.
    Wu, J. J.
    Feldman, S. R.
    Armstrong, A. W.
    VALUE IN HEALTH, 2019, 22 : S52 - S52
  • [49] Cost-effectiveness and budget impact analyses of tisagenlecleucel in adult patients with relapsed or refractory diffuse large B-cell lymphoma from Singapore's private insurance payer's perspective
    Wang, Xiao Jun
    Wang, Yi-Ho
    Li, Shing Chau Tony
    Gkitzia, Christina
    Lim, Soon Thye
    Koh, Liang Piu
    Lim, Francesca Lorraine Wei Inng
    Hwang, William Ying Khee
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 637 - 653
  • [50] Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis
    Jiang, Xinchan
    Yao, Jiaqi
    You, Joyce H. S.
    JMIR MHEALTH AND UHEALTH, 2020, 8 (07):